ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Accolade Inc

Accolade Inc (ACCD)

3.95
0.21
(5.61%)
Closed July 23 4:00PM
3.869
-0.081
( -2.05% )
Pre Market: 8:50AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.869
Bid
3.75
Ask
3.95
Volume
2,987
0.00 Day's Range 0.00
3.35 52 Week Range 15.36
Market Cap
Previous Close
3.95
Open
-
Last Trade Time
08:50:01
Financial Volume
-
VWAP
-
Average Volume (3m)
1,451,053
Shares Outstanding
80,008,376
Dividend Yield
-
PE Ratio
-3.17
Earnings Per Share (EPS)
-1.25
Revenue
414.29M
Net Profit
-99.81M

About Accolade Inc

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members. Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Sector
Business Services, Nec
Industry
Business Services, Nec
Headquarters
Wilmington, Delaware, USA
Founded
1970
Accolade Inc is listed in the Business Services sector of the NASDAQ with ticker ACCD. The last closing price for Accolade was $3.95. Over the last year, Accolade shares have traded in a share price range of $ 3.35 to $ 15.36.

Accolade currently has 80,008,376 shares outstanding. The market capitalization of Accolade is $316.03 million. Accolade has a price to earnings ratio (PE ratio) of -3.17.

ACCD Latest News

Nike Stock Drops 14% in Pre-Market; Nokia Acquires Infinera for $2.3 Billion, and More News

Nike (NYSE:NKE) – Nike shares fell 14.04% in pre-market trading. Nike exceeded fourth-quarter fiscal earnings estimates with adjusted earnings of $1.01 per share, but sales of $12.6 billion...

Accolade Announces Results for Fiscal First Quarter 2025

SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy...

U.S. Futures Decline Ahead of Key Economic Events, Oil Prices Rise

U.S. index futures point to a lower opening on Thursday, influenced by a disappointing revenue forecast from chipmaker Micron Technology (NASDAQ:MU), with focus on the release of Q1 GDP this...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0290.7552083333333.844.04993.3716694033.69946936CS
4-2.071-34.86531986535.946.413.3530154763.76324161CS
12-3.711-48.95778364127.588.053.3514510534.71309213CS
26-8.061-67.569153394811.9313.933.3510091746.58416342CS
52-9.481-71.018726591813.3515.363.358179718.2219007CS
156-45.031-92.087934560348.949.473.3585284612.74374404CS
260-31.131-88.94571428573565.253.3579139819.51694094CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 4.68
(354.37%)
34.37M
DRMADermata Therapeutics Inc
$ 3.15
(142.31%)
21.2M
BBLGBone Biologics Corporation
$ 2.24
(79.20%)
12.52M
PIRSPieris Pharmaceuticals Inc
$ 14.00
(75.44%)
1.28M
SGMOSangamo Therapeutics Inc
$ 0.6788
(69.15%)
23.92M
CONNConns Inc
$ 0.314
(-38.07%)
316.54k
NUWENewellis Inc
$ 2.60
(-37.35%)
160.21k
ATPCAgape ATP Corporation
$ 0.1521
(-29.26%)
993.18k
VWEVintage Wine Estates Inc
$ 0.08
(-28.51%)
2.32M
VSTMVerastem Inc
$ 2.68
(-25.35%)
259.91k
SLNASelina Hospitality PLC
$ 0.0252
(-3.08%)
44.37M
ALLRAllarity Therapeutics Inc
$ 0.1845
(10.81%)
40.36M
NUZENuZee Inc
$ 4.70
(356.31%)
34.37M
SGMOSangamo Therapeutics Inc
$ 0.6712
(67.26%)
23.93M
HOTHHoth Therapeutics Inc
$ 1.22
(25.52%)
22.61M

ACCD Discussion

View Posts
Monksdream Monksdream 4 weeks ago
ACCD new 52 week low
👍️0
Monksdream Monksdream 11 months ago
That awful Cathie Wood bought more shares

👍️0
Monksdream Monksdream 12 months ago
ACCD That awful Cathie Wood bought shares.
Accolade Inc NASDAQ: ACCD

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
👍️0
forthepeach forthepeach 2 years ago
Will this help their stock price?
https://finance.yahoo.com/news/accolade-expands-mental-health-integrated-130000009.html
👍️0
swampboots swampboots 2 years ago
ACCD down 50% will lose big customer end of year and always has loses on increased revenue, spends a ton on research and dev.
👍️0
crudeoil24 crudeoil24 3 years ago
Accolade Sees Q4 Sales $90M-$93M vs $97.71M Est., Raises FY22 Sales Guidance From $303M-$307M To $306M-$309M vs $306.34M Est.
👍️0
crudeoil24 crudeoil24 3 years ago
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The Company leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
👍️0

Your Recent History

Delayed Upgrade Clock